120 related articles for article (PubMed ID: 3307632)
1. [Phase II study of chlorambucil in patients with hematological malignancies].
Inoue K; Ogawa M; Horikoshi N; Mukaiyama T; Itoh Y; Imajoh K; Ozeki H; Nagamine D; Shinagawa K
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2672-5. PubMed ID: 3307632
[TBL] [Abstract][Full Text] [Related]
2. [Early phase II trial of bestrabucil in hematological malignancies].
Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
[TBL] [Abstract][Full Text] [Related]
3. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
[TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of bestrabucil (KM 2210) on hematopoietic malignancies].
Nishikawa M; Uemura Y; Matsuoka N; Ohno T; Katayama N; Tomeoku M; Kobayashi T; Kita K; Tanaka H; Minami N
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2155-9. PubMed ID: 3521494
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
Rohatiner A; Radford J; Deakin D; Earl H; Love SB; Price O; Wilson A; Lister TA
Br J Cancer; 2001 Jul; 85(1):29-35. PubMed ID: 11437398
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Prednimustine (Leo 1031) in chronic lymphatic leukemia].
Lutz D; Böhnel J
Osterr Z Onkol; 1977; 3(5-6):155-9. PubMed ID: 323777
[TBL] [Abstract][Full Text] [Related]
7. [Bestrabucil-induced complete remission in a case of follicular lymphoma, medium-sized cell type, stage IV (leukemic)].
Hirano M; Shirakawa S
Gan No Rinsho; 1986 Sep; 32(11):1491-4. PubMed ID: 3534347
[TBL] [Abstract][Full Text] [Related]
8. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
[TBL] [Abstract][Full Text] [Related]
9. [A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].
Kimura K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):368-75. PubMed ID: 3947112
[TBL] [Abstract][Full Text] [Related]
10. [KM 2210 therapy for chronic lymphocytic leukemia].
Mori M; Murai Y; Miwa A; Fukayama M; Ikebuchi K; Nakamura N; Kaise M
Gan No Rinsho; 1983 Dec; 29(15):1788-90. PubMed ID: 6689433
[TBL] [Abstract][Full Text] [Related]
11. High-dose pulse chlorambucil in advanced, low-grade non-Hodgkin's lymphoma.
Portlock CS; Fischer DS; Cadman E; Lundberg WB; Levy A; Bobrow S; Bertino JR; Farber L
Cancer Treat Rep; 1987 Nov; 71(11):1029-31. PubMed ID: 3677110
[TBL] [Abstract][Full Text] [Related]
12. [Utility of daily oral administration of etoposide in 25 cases of refractory hematological malignancies].
Kuga T; Kohda K; Matsumoto S; Nakazawa O; Ezoe A; Nobuoka A; Mochizuki C; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1997 Feb; 24(3):315-21. PubMed ID: 9051134
[TBL] [Abstract][Full Text] [Related]
13. [Late phase II study with 21-consecutive-day oral administration of etoposide for malignant lymphoma].
Yoshida T; Takagi T; Shimoyama M; Mikuni C; Suzuki K; Egami K; Furusawa S; Nomura T; Mori M; Sugimoto T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2793-801. PubMed ID: 7993116
[TBL] [Abstract][Full Text] [Related]
14. Biweekly chlorambucil treatment of lymphocytic lymphoma.
Knospe WH; Loeb V
Cancer Clin Trials; 1980; 3(4):329-36. PubMed ID: 7428139
[TBL] [Abstract][Full Text] [Related]
15. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Levy M; Copie-Bergman C; Traulle C; Lavergne-Slove A; Brousse N; Flejou JF; de Mascarel A; Hemery F; Gaulard P; Delchier JC;
Am J Gastroenterol; 2002 Feb; 97(2):292-7. PubMed ID: 11866264
[TBL] [Abstract][Full Text] [Related]
16. Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia.
Giles FJ; Cortes JE; Thomas DA; Garcia-Manero G; Faderl S; Jeha S; De Jager RL; Kantarjian HM
Clin Cancer Res; 2002 Jul; 8(7):2134-41. PubMed ID: 12114413
[TBL] [Abstract][Full Text] [Related]
17. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Bremer K
J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
[TBL] [Abstract][Full Text] [Related]
18. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
[TBL] [Abstract][Full Text] [Related]
19. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group.
Bergmann MA; Goebeler ME; Herold M; Emmerich B; Wilhelm M; Ruelfs C; Boening L; Hallek MJ;
Haematologica; 2005 Oct; 90(10):1357-64. PubMed ID: 16219572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
